News | Infectious Disease

Nigeria leads a global effort to  combat meningitis with the introduction of a revolutionary 5-in-1 Meningitis Vaccine
Time to read: 1 minute, 17 seconds
 
Published on MedED:  14 April 2024
Type of article: News
MedED Catalogue Reference: MNG0028

Category: News | Public Health
Category Cross-reference: Infectious Diseases

Keywords: meningitis, viral meningitis, immunisation, vaccination 

 




14 April 2024, 14:45

Nigeria has made history by rolling out a new vaccine for the prevention of meningitis. Men5CV®, which the WHO endorses, is effective against five strains of meningococcus bacteria. The rollout of the vaccine program took place in northern Nigeria, with over a million doses administered to individuals between the ages of 1 and 29 years of age during the period 25 - 29 March 2024.

Nigeria is one of 26 meningitis hyper-endemic African countries, with the region reporting a 50% increase in meningitis cases last year. Nigeria, in particular, faced a severe outbreak of Neisseria meningitides serogroup C, resulting in a high number of cases and deaths across its seven states.

The Men5CV ® vaccine offers a comprehensive shield against five major meningococcal strains, providing broader protection compared to existing vaccines, which are effective only against the A strain. Its introduction is a major step forward in reducing the disease's burden, particularly in regions like Nigeria, where multiple serogroups are prevalent.  
.
This initiative aligns with WHO's global roadmap to defeat meningitis by 2030, which aims to eliminate epidemics, reduce cases and deaths, and improve quality of life post-meningitis.

 

Related content

The WHO: Global roadmap to defeating meningitis by 2030
Data Generated by Researchers at MRCG at the LSHTM Directly Impact WHO Vaccine Policy


Disclaimer
This article is compiled from various resources researched and compiled by the contributor. It is in no way presented as an original work.  Every effort has been made to correctly attribute quotes and content. Where possible all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us 


Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.

Rapid SSL

The Medical Education Network
Powered by eLecture, a VisualLive Solution